GARDNER, Mass., Aug.12, 2019 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the "Company") today announced that it has scheduled a conference call to discuss preliminary fourth quarter and fiscal 2019 revenue as well as its recent acquisition of Ross Optical Industries on Thursday, August 15, 2019 at 5:00pm ET.

WASHINGTON, Aug. 12, 2019 /PRNewswire/ -- Today, the Department of Homeland Security (DHS) finalized a new rule that will deter use of vital services for some immigrant populations. Fourteen patient groups released the following statement in response to this rule being finalized:"Our organizations represent millions of patients and consumers, including many

LAKE FOREST, Calif., Aug. 12, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq:INMD) ("InMode") announced today the closing of its initial public offering of 5,000,000 ordinary shares at an initial public offering price of $14.00 per ordinary share. The aggregate gross proceeds, before deducting underwriting discounts and commissions and other

SAN JOSE, Calif., Aug. 12, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of targeted immunotherapies using fully human monoclonal antibodies (mAbs) to treat life-threatening bacterial infections, today reported financial and corporate results for the second quarter ended&

SAN DIEGO, Aug. 12, 2019 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to i

AUSTIN, Texas, Aug. 12, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the second quarter ended June 30, 2019. Volition management will host a conference call tomorrow, August 13, at 8:30 a.m.

DUBLIN, Aug. 12, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the acquisition of Cavion, Inc. through a merger with a Jazz subsidiary.  Under the terms of the agreement, the former Cavion shareholders receive an upfront payment of $52.5 million and have the potential to receive additional payments of

SOUTH SAN FRANCISCO, Calif., Aug. 12, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics, provided a business update and announced financial results for the second quarter ended

Customers Choose from a Wider Spectrum of Flavor Profiles  BOSTON, Aug. 12, 2019 /PRNewswire/ -- Conagen, a Boston-based biotechnology company focusing on research and development, announced today its breakthrough development in the commercial production of natural aromatic compound, γ-Decalactone from natural s

WEST COLUMBIA, S.C., Aug. 12, 2019 /PRNewswire/ -- Nephron Pharmaceuticals Corporation is partnering with Clemson University to create a robotic solution for syringe-filling automation to enhance sterile manufacturing in the pharmaceutical production process and keep up with growing hospital demands.